These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 7852525)

  • 1. Gonadotroph adenoma in a premenopausal woman secreting follicle-stimulating hormone and causing ovarian hyperstimulation.
    Djerassi A; Coutifaris C; West VA; Asa SL; Kapoor SC; Pavlou SN; Snyder PJ
    J Clin Endocrinol Metab; 1995 Feb; 80(2):591-4. PubMed ID: 7852525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian hyperstimulation without elevated serum estradiol associated with pure follicle-stimulating hormone-secreting pituitary adenoma.
    Shimon I; Rubinek T; Bar-Hava I; Nass D; Hadani M; Amsterdam A; Harel G
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3635-40. PubMed ID: 11502789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian hyperstimulation syndrome caused by pituitary gonadotroph adenoma secreting follicle-stimulating hormone.
    Ghayuri M; Liu JH
    Obstet Gynecol; 2007 Feb; 109(2 Pt2):547-9. PubMed ID: 17267890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian hyperstimulation caused by gonadotroph adenoma secreting follicle-stimulating hormone in 28-year-old woman.
    Välimäki MJ; Tiitinen A; Alfthan H; Paetau A; Poranen A; Sane T; Stenman UH
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4204-8. PubMed ID: 10566673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotroph adenoma causing ovarian hyperstimulation syndrome in a premenopausal woman.
    Halupczok J; Bidzińska-Speichert B; Lenarcik-Kabza A; Zieliński G; Filus A; Maksymowicz M
    Gynecol Endocrinol; 2014 Nov; 30(11):774-7. PubMed ID: 24971660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of clinical symptoms in a young woman with a recurrent gonadotroph adenoma causing ovarian hyperstimulation.
    Pentz-Vidovíc I; Skorić T; Grubisić G; Korsíc M; Ivicevic-Bakulic T; Besenski N; Paladino J; Plavsic V; Zarković K
    Eur J Endocrinol; 2000 Nov; 143(5):607-14. PubMed ID: 11078984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of follicle-stimulating hormone secretion from gonadotroph adenomas by repetitive administration of a gonadotropin-releasing hormone antagonist.
    Daneshdoost L; Pavlou SN; Molitch ME; Gennarelli TA; Savino PJ; Sergott RC; Bosley TM; River JE; Vale WW; Snyder PJ
    J Clin Endocrinol Metab; 1990 Jul; 71(1):92-7. PubMed ID: 2115048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gonadotroph cell adenomas of the pituitary.
    Snyder PJ
    Endocr Rev; 1985; 6(4):552-63. PubMed ID: 2416559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful pregnancy after bromocriptine therapy in an anovulatory woman complicated with ovarian hyperstimulation caused by follicle-stimulating hormone-producing plurihormonal pituitary microadenoma.
    Murata Y; Ando H; Nagasaka T; Takahashi I; Saito K; Fukugaki H; Matsuzawa K; Mizutani S
    J Clin Endocrinol Metab; 2003 May; 88(5):1988-93. PubMed ID: 12727942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful pregnancy and delivery after removal of gonadotrope adenoma secreting follicle-stimulating hormone in a 29-year-old amenorrheic woman.
    Sugita T; Seki K; Nagai Y; Saeki N; Yamaura A; Ohigashi S; Iwata A; Tatsuno I; Sekiya S
    Gynecol Obstet Invest; 2005; 59(3):138-43. PubMed ID: 15637432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New technique for quantitation of pituitary adenoma size: use in evaluating treatment of gonadotroph adenomas with a gonadotropin-releasing hormone antagonist.
    McGrath GA; Goncalves RJ; Udupa JK; Grossman RI; Pavlou SN; Molitch ME; Rivier J; Vale WW; Snyder PJ
    J Clin Endocrinol Metab; 1993 May; 76(5):1363-8. PubMed ID: 8496331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of gonadotroph adenomas in men with clinically nonfunctioning adenomas by the luteinizing hormone beta subunit response to thyrotropin-releasing hormone.
    Daneshdoost L; Gennarelli TA; Bashey HM; Savino PJ; Sergott RC; Bosley TM; Snyder PJ
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1352-5. PubMed ID: 8077332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pituitary adenoma secreting follicle-stimulating hormone with ovarian hyperstimulation: treatment using a gonadotropin-releasing hormone antagonist.
    Garmes HM; Grassiotto OR; Fernandes YB; Queiroz Lde S; Vassalo J; de Oliveira DM; Benetti-Pinto CL
    Fertil Steril; 2012 Jan; 97(1):231-4. PubMed ID: 22118994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gonadotroph pituitary adenomas].
    Chanson P
    Ann Endocrinol (Paris); 2000 Sep; 61(3):258-68. PubMed ID: 10970952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A functioning FSH-secreting pituitary macroadenoma causing an ovarian hyperstimulation syndrome with multiple cysts resected and relapsed after leuprolide in a reproductive-aged woman.
    Macchia E; Simoncini T; Raffaelli V; Lombardi M; Iannelli A; Martino E
    Gynecol Endocrinol; 2012 Jan; 28(1):56-9. PubMed ID: 21770827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadotroph adenoma with secondary hypersecretion of testosterone.
    Chamoun R; Layfield L; Couldwell WT
    World Neurosurg; 2013 Dec; 80(6):900.e7-11. PubMed ID: 23201183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison between the diagnostic value of gonadotropins, alpha-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha-subunit-secreting, and gonadotroph pituitary adenomas.
    Nobels FR; Kwekkeboom DJ; Coopmans W; Hoekstra R; De Herder WW; Bouillon R; Lamberts SW
    J Clin Endocrinol Metab; 1993 Sep; 77(3):784-9. PubMed ID: 7690365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of hormonal secretory behavior of gonadotroph cell adenomas in vivo and in culture.
    Snyder PJ; Bashey HM; Phillips JL; Gennarelli TA
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1061-5. PubMed ID: 2414310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of ovarian hyperstimulation due to follicle-stimulating hormone-secreting gonadotroph adenoma.
    Murakami T; Higashitsuji H; Yoshinaga K; Terada Y; Ito K; Ikeda H
    BJOG; 2004 Nov; 111(11):1297-300. PubMed ID: 15521879
    [No Abstract]   [Full Text] [Related]  

  • 20. Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors.
    Klibanski A; Jameson JL; Biller BM; Crowley WF; Zervas NT; Rivier J; Vale WW; Bikkal H
    J Clin Endocrinol Metab; 1989 Jan; 68(1):81-6. PubMed ID: 2535852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.